Related Experiment Video
Updated: Sep 28, 2025

08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.2K
ELIXIR biovalidator for semantic validation of life science metadata
Isuru Liyanage1, Tony Burdett1, Bert Droesbeke2,3
1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton CB10 1SD, UK.
Bioinformatics (Oxford, England)
|April 5, 2022
Summary
The ELIXIR biovalidator enhances biomedical data integration by adding ontology-based validation to existing JSON schema validation. This ensures accurate data discovery and shared understanding for advancing research.
Area of Science:
- Biomedical Informatics
- Data Science
- Bioinformatics
Background:
- Advancing biomedical research necessitates the discovery and integration of large, complex datasets.
- Ensuring shared understanding of data entities requires robust syntactic and semantic validation.
Purpose of the Study:
- To introduce the ELIXIR biovalidator, a tool designed to improve biomedical data validation.
- To extend existing JSON validation capabilities with ontology-based semantic checks.
Main Methods:
- The ELIXIR biovalidator integrates ontology-based validation with the AJV (Another JSON Schema Validator) library.
- It performs syntactic validation using AJV and semantic validation against ontologies for JSON documents.
Main Results:
- The biovalidator provides enhanced validation for biomedical data.
- It facilitates more reliable data integration and discovery by ensuring semantic consistency.
Conclusions:
- The ELIXIR biovalidator is a valuable tool for advancing biomedical research through improved data validation.
- It supports the creation of a shared understanding of biomedical entities within complex datasets.
More Related Videos
Related Concept Videos
Data Validation
278
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
Key parameters for method validation include:
278
Enzyme-Linked Immunosorbent Assay
14.6K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
14.6K

